NCT02276352View on ClinicalTrials.gov

Relative Bioavailability of Meloxicam 2 x 7.5 mg Tablets Compared to 15 mg Tablet and Dose Proportionality Over a Dose Range of 7.5 mg and 15 mg in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 30, 1999

Primary Completion Date

August 31, 1999

Conditions
Healthy
Interventions
DRUG

Treatment 1

DRUG

Treatment 2

DRUG

Treatment 3

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY